We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
+14.69%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$26.8B
AUM Growth
+$3.21B
(+14%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
0.63%
Top 10 Holdings %
Top 10 Hldgs %
33.69%
Holding
1,279
New
177
Increased
369
Reduced
457
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$161M |
| 2 |
Target
TGT
|
+$149M |
| 3 |
Amgen
AMGN
|
+$142M |
| 4 |
Ross Stores
ROST
|
+$120M |
| 5 |
3M
MMM
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$123M |
| 2 |
Eli Lilly
LLY
|
+$110M |
| 3 |
Cisco
CSCO
|
+$109M |
| 4 |
Adobe
ADBE
|
+$98.2M |
| 5 |
Newmont
NEM
|
+$94.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.52% |
| 2 | Consumer Discretionary | 14.2% |
| 3 | Financials | 13.06% |
| 4 | Industrials | 10.11% |
| 5 | Communication Services | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Beam Therapeutics
BEAM
$2.76B
| $487K | ﹤0.01% |
17,892
-6,873
| -28% | -$171K |
|
877
Rhythm Pharmaceuticals
RYTM
$8.1B
| $487K | ﹤0.01% |
10,593
-2,828
| -21% | -$89.2K |
|
878
Check Point Software Technologies
CHKP
$13.2B
| $486K | ﹤0.01% |
3,180
| – | – |
|
879
Utah Medical Products
UTMD
$230M
| $486K | ﹤0.01% |
5,766
| – | – |
|
880
California Resources
CRC
$4.75B
| $485K | ﹤0.01% |
8,873
-3,400
| -28% | -$179K |
|
881
PBF Energy
PBF
$8.34B
| $483K | ﹤0.01% |
10,980
-49,097
| -82% | -$2.23M |
|
882
Century Casinos
CNTY
$34.3M
| $483K | ﹤0.01% |
98,887
| – | – |
|
883
Futu Holdings
FUTU
$14.7B
| $480K | ﹤0.01% |
8,790
-7,982
| -48% | -$453K |
|
|
BIG
884
DELISTED
Big Lots, Inc.
BIG
| $479K | ﹤0.01% |
+61,430
| New | +$317K |
|
|
EGRX
885
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $477K | ﹤0.01% |
91,262
+36,982
| +68% | +$365K |
|
886
Southern Copper
SCCO
$165B
| $477K | ﹤0.01% |
6,052
-38,942
| -87% | -$2.68M |
|
|
STEL
887
DELISTED
Stellar Bancorp
STEL
| $475K | ﹤0.01% |
17,058
+700
| +4% | +$16.8K |
|
888
Northrim BanCorp
NRIM
$599M
| $475K | ﹤0.01% |
33,200
+8,560
| +35% | +$101K |
|
889
Midland States Bancorp
MSBI
$696M
| $470K | ﹤0.01% |
+17,043
| New | +$396K |
|
890
Alector
ALEC
$240M
| $469K | ﹤0.01% |
58,756
-111,442
| -65% | -$660K |
|
891
Kodiak Sciences
KOD
$2.72B
| $468K | ﹤0.01% |
154,099
| – | – |
|
892
Advantage Solutions
ADV
$399M
| $467K | ﹤0.01% |
5,159
+866
| +20% | +$61.6K |
|
893
BancFirst
BANF
$3.84B
| $467K | ﹤0.01% |
+4,796
| New | +$420K |
|
|
CHX
894
DELISTED
ChampionX
CHX
| $466K | ﹤0.01% |
15,958
-21,068
| -57% | -$652K |
|
895
Warrior Met Coal
HCC
$5.11B
| $461K | ﹤0.01% |
7,554
-2,380
| -24% | -$126K |
|
896
InMode
INMD
$876M
| $460K | ﹤0.01% |
20,682
-13,234
| -39% | -$297K |
|
|
MRSN
897
DELISTED
Mersana Therapeutics
MRSN
| $458K | ﹤0.01% |
7,899
| – | – |
|
898
Coherus Oncology
CHRS
$181M
| $456K | ﹤0.01% |
136,820
+61,722
| +82% | +$165K |
|
|
GBIO
899
DELISTED
Generation Bio
GBIO
| $455K | ﹤0.01% |
27,583
+20,946
| +316% | +$365K |
|
900
Ralph Lauren
RL
$23.6B
| $455K | ﹤0.01% |
+3,155
| New | +$391K |
|
Similar funds
VAI
Los Angeles Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Los Angeles Capital Management held 1,279 positions worth $26.8B, up 14% from $23.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Los Angeles Capital Management's Q4 2023 filing shows 177 new, 369 increased, 457 reduced and 160 closed positions. Its largest new stake was Capital One: 352,866 shares worth $46.3M. The largest sale was Visa, an estimated $123M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Financials.
- Los Angeles Capital Management's largest Q4 2023 buy was Capital One: 352,866 shares worth $46.3M.
- Los Angeles Capital Management added most to Starbucks in Q4 2023, an estimated $161M increase.
- Los Angeles Capital Management's biggest Q4 2023 reduction was Visa, cutting an estimated $123M.
- Los Angeles Capital Management fully exited Brown-Forman Class B in Q4 2023, selling an estimated $45M.
- Los Angeles Capital Management's ten largest holdings make up 34% of its $26.8B portfolio in Q4 2023.
- Los Angeles Capital Management opened 177 new positions and closed 160 in Q4 2023.
- Los Angeles Capital Management's portfolio value rose 14% quarter-over-quarter to $26.8B.
Based on Los Angeles Capital Management's 13F filing for Q4 2023, filed 6 Feb 2024.